RAF Mutation
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors (NCT07121829) | Day One Biopharmaceuticals, Inc. | 2022-05-02 |
| Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors (NCT04985604) | Day One Biopharmaceuticals, Inc. | 2021-07-15 |
Track RAF Mutation automatically
Every clearance here is in the API, with alerts when new ones post.